• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注射水凝胶作为递药系统在骨关节炎和类风湿关节炎中的应用。

Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis.

机构信息

Department of Rheumatology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.

The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.

出版信息

Br J Hosp Med (Lond). 2024 Aug 30;85(8):1-41. doi: 10.12968/hmed.2024.0347.

DOI:10.12968/hmed.2024.0347
PMID:39212571
Abstract

Osteoarthritis and rheumatoid arthritis, though etiologically distinct, are both inflammatory joint diseases that cause progressive joint injury, chronic pain, and loss of function. Therefore, long-term treatment with a focus on relieving symptoms is needed. At present, the primary treatment for arthritis is drug therapy, both oral and intravenous. Although significant progress has been achieved for these treatment methods in alleviating symptoms, certain prominent drawbacks such as the substantial side effects and limited absorption of medications call for an urgent need for improved drug delivery methods. Injected hydrogels can be used as a delivery system to deliver drugs to the joint cavity in a controlled manner and continuously release them, thereby enhancing drug retention in the joint cavity to improve therapeutic effectiveness, which is attributed to the desirable attributes of the delivery system such as low immunogenicity, good biodegradability and biocompatibility. This review summarizes the types of injectable hydrogels and analyzes their applications as delivery systems in arthritis treatment. We also explored how hydrogels counteract inflammation, bone and cartilage degradation, and oxidative stress, while promoting joint cartilage regeneration in the treatment of osteoarthritis (OA) and rheumatoid arthritis (RA). This review also highlights new approaches to developing injectable hydrogels as delivery systems for OA and RA.

摘要

骨关节炎和类风湿关节炎虽然病因不同,但都是炎症性关节疾病,可导致进行性关节损伤、慢性疼痛和功能丧失。因此,需要长期以缓解症状为重点进行治疗。目前,关节炎的主要治疗方法是药物治疗,包括口服和静脉注射。尽管这些治疗方法在缓解症状方面取得了显著进展,但药物的大量副作用和吸收有限等突出缺点需要迫切改进药物输送方法。注射水凝胶可用作药物输送系统,以受控方式将药物递送到关节腔中并持续释放,从而提高关节腔中药物的保留率,以提高治疗效果,这归因于输送系统的理想特性,如低免疫原性、良好的生物降解性和生物相容性。本文综述了可注射水凝胶的类型,并分析了它们作为关节炎治疗中药物输送系统的应用。我们还探讨了水凝胶如何在治疗骨关节炎 (OA) 和类风湿关节炎 (RA) 中对抗炎症、骨和软骨降解以及氧化应激,同时促进关节软骨再生。本文还强调了开发用于 OA 和 RA 的可注射水凝胶作为药物输送系统的新方法。

相似文献

1
Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis.注射水凝胶作为递药系统在骨关节炎和类风湿关节炎中的应用。
Br J Hosp Med (Lond). 2024 Aug 30;85(8):1-41. doi: 10.12968/hmed.2024.0347.
2
Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis.用于骨关节炎和类风湿性关节炎的注射给药系统
ACS Nano. 2022 Dec 27;16(12):19665-19690. doi: 10.1021/acsnano.2c06393. Epub 2022 Dec 13.
3
A novel indomethacin/methotrexate/MMP-9 siRNA in situ hydrogel with dual effects of anti-inflammatory activity and reversal of cartilage disruption for the synergistic treatment of rheumatoid arthritis.一种新型的吲哚美辛/甲氨蝶呤/MMP-9 siRNA 原位水凝胶,具有抗炎活性和逆转软骨破坏的双重作用,用于类风湿关节炎的协同治疗。
Nanoscale. 2020 Apr 21;12(15):8546-8562. doi: 10.1039/d0nr00454e. Epub 2020 Apr 3.
4
Intra-Articular Injectable Biomaterials for Cartilage Repair and Regeneration.关节内注射用生物材料在软骨修复和再生中的应用
Adv Healthc Mater. 2024 Jul;13(17):e2303794. doi: 10.1002/adhm.202303794. Epub 2024 Apr 8.
5
Intra-articular hydrogel formulation prolongs the in vivo stability of Toll-like receptor antagonistic peptides for rheumatoid arthritis treatment.关节内水凝胶制剂延长了用于治疗类风湿关节炎的 Toll 样受体拮抗剂肽的体内稳定性。
J Control Release. 2024 Aug;372:467-481. doi: 10.1016/j.jconrel.2024.06.034. Epub 2024 Jun 27.
6
Enhanced intra-articular therapy for rheumatoid arthritis using click-crosslinked hyaluronic acid hydrogels loaded with toll-like receptor antagonizing peptides.采用点击交联透明质酸水凝胶负载 Toll 样受体拮抗肽增强类风湿关节炎的关节内治疗。
Acta Biomater. 2023 Dec;172:188-205. doi: 10.1016/j.actbio.2023.10.023. Epub 2023 Oct 21.
7
Advances in local drug delivery technologies for improved rheumatoid arthritis therapy.局部药物递送技术的进展改善类风湿性关节炎治疗
Adv Drug Deliv Rev. 2024 Jun;209:115325. doi: 10.1016/j.addr.2024.115325. Epub 2024 Apr 24.
8
Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast like synoviocytes (hFLS) of RA patients.用于类风湿性关节炎(RA)中药物控释的自驱动炎症响应水凝胶微球制剂:动物试验及对RA患者人成纤维样滑膜细胞(hFLS)的研究
Biomater Adv. 2024 Jun;160:213853. doi: 10.1016/j.bioadv.2024.213853. Epub 2024 Apr 16.
9
Progress in intra-articular drug delivery systems for osteoarthritis.骨关节炎关节内给药系统的进展
Curr Drug Targets. 2014;15(9):888-900. doi: 10.2174/1389450115666140804155830.
10
An overview of hydrogel-based intra-articular drug delivery for the treatment of osteoarthritis.用于治疗骨关节炎的水凝胶基关节内药物递送概述
Colloids Surf B Biointerfaces. 2017 Jun 1;154:33-39. doi: 10.1016/j.colsurfb.2017.03.003. Epub 2017 Mar 6.

引用本文的文献

1
Recent Evidence for Orthobiologics Combined with Hydrogels for Joint Tissue Regeneration: Focus on Osteoarthritis.用于关节组织再生的正骨科生物制剂联合水凝胶的最新证据:聚焦骨关节炎
Gels. 2025 Jul 17;11(7):551. doi: 10.3390/gels11070551.